Alexander Gallus

Summary

Affiliation: Flinders University
Country: Australia

Publications

  1. ncbi Applying risk assessment models in orthopaedic surgery: overview of our clinical experience
    A S Gallus
    Flinders Medical Centre, Department of Haematology, Flinders University School of Medicine, Bedford Park, SA, Australia
    Blood Coagul Fibrinolysis 10:S53-61. 1999
  2. ncbi Which patients with venous thromboembolism are at risk for fatal pulmonary embolism?
    Alexander Gallus
    Department of Haematology and Genetic Pathology, Flinders University School of Medicine, Flinders Medical Centre, Adelaide, Australia
    Nat Clin Pract Cardiovasc Med 5:604-5. 2008
  3. ncbi Management options for thrombophilias
    Alexander S Gallus
    Flinders Medical Centre, Adelaide, South Australia, Australia
    Semin Thromb Hemost 31:118-26. 2005
  4. ncbi Travel, venous thromboembolism, and thrombophilia
    Alexander S Gallus
    Flinders Medical Centre, Adelaide, South Australia, Australia
    Semin Thromb Hemost 31:90-6. 2005
  5. ncbi New aspects of the blood coagulation cascade, anticoagulants and vein thrombosis in Asia
    A S Gallus
    Department of Haematology, Flinders Medical Centre, Bedford Park 5042, South Australia, Australia
    Ann Acad Med Singapore 31:685-96. 2002
  6. ncbi Heparin pentasaccharide
    Alexander S Gallus
    Department of Haematology, Flinders Medical Centre, Belford Park, SA 5042, Adelaide, Australia
    Curr Opin Hematol 9:422-9. 2002
  7. ncbi Travel and venous thrombosis
    Alexander S Gallus
    Department of Hematology, Flinders Medical Center, Adelaide, Australia
    Curr Opin Pulm Med 8:372-8. 2002
  8. ncbi Preventing venous thromboembolism in general medical inpatients and after an ischaemic stroke
    A S Gallus
    Department of Haematology, Flinders Medical Centre, Bedford Park, Australia
    Haemostasis 30:64-71; discussion 63. 2000
  9. ncbi Accuracy and clinical usefulness of the CoaguChek S and XS Point of Care devices when starting warfarin in a hospital outreach setting
    Magdalena Sobieraj-Teague
    Flinders Medical Centre, Department of Haematology, Bedford Park, South Australia 5042
    Thromb Res 123:909-13. 2009
  10. ncbi Warfarin and acetaminophen interaction
    Markus G Gebauer
    Pharmacy Department Repatriation General Hospital, Adelaide, South Australia, Australia
    Pharmacotherapy 23:109-12. 2003

Collaborators

Detail Information

Publications15

  1. ncbi Applying risk assessment models in orthopaedic surgery: overview of our clinical experience
    A S Gallus
    Flinders Medical Centre, Department of Haematology, Flinders University School of Medicine, Bedford Park, SA, Australia
    Blood Coagul Fibrinolysis 10:S53-61. 1999
    ..Ever shorter hospital admissions after elective surgery mean that prophylaxis given only in hospital may not be sufficient...
  2. ncbi Which patients with venous thromboembolism are at risk for fatal pulmonary embolism?
    Alexander Gallus
    Department of Haematology and Genetic Pathology, Flinders University School of Medicine, Flinders Medical Centre, Adelaide, Australia
    Nat Clin Pract Cardiovasc Med 5:604-5. 2008
    ..These results reinforce previous observations that also linked symptomatic PE, massive PE, old age, and cancer to a raised likelihood of death from PE despite appropriate therapy...
  3. ncbi Management options for thrombophilias
    Alexander S Gallus
    Flinders Medical Centre, Adelaide, South Australia, Australia
    Semin Thromb Hemost 31:118-26. 2005
    ....
  4. ncbi Travel, venous thromboembolism, and thrombophilia
    Alexander S Gallus
    Flinders Medical Centre, Adelaide, South Australia, Australia
    Semin Thromb Hemost 31:90-6. 2005
    ..Whether this surrogate outcome measure translates into clinical benefit remains unknown, but support stockings are likely to be more effective and have less adverse effects than the use of aspirin...
  5. ncbi New aspects of the blood coagulation cascade, anticoagulants and vein thrombosis in Asia
    A S Gallus
    Department of Haematology, Flinders Medical Centre, Bedford Park 5042, South Australia, Australia
    Ann Acad Med Singapore 31:685-96. 2002
    ..New anticoagulants were even more effective in recent trials. There is urgent need for studies in Asia that define the locally relevant benefits and hazards of the increasing range of agents now available...
  6. ncbi Heparin pentasaccharide
    Alexander S Gallus
    Department of Haematology, Flinders Medical Centre, Belford Park, SA 5042, Adelaide, Australia
    Curr Opin Hematol 9:422-9. 2002
    ..Results of phase III treatment trials for DVT/PE will soon be available, but studies in coronary artery disease are less advanced...
  7. ncbi Travel and venous thrombosis
    Alexander S Gallus
    Department of Hematology, Flinders Medical Center, Adelaide, Australia
    Curr Opin Pulm Med 8:372-8. 2002
    ..This makes it sensible to target such "at risk" people with advice about hazards and precautions, at least until formal study validates some other approach...
  8. ncbi Preventing venous thromboembolism in general medical inpatients and after an ischaemic stroke
    A S Gallus
    Department of Haematology, Flinders Medical Centre, Bedford Park, Australia
    Haemostasis 30:64-71; discussion 63. 2000
    ....
  9. ncbi Accuracy and clinical usefulness of the CoaguChek S and XS Point of Care devices when starting warfarin in a hospital outreach setting
    Magdalena Sobieraj-Teague
    Flinders Medical Centre, Department of Haematology, Bedford Park, South Australia 5042
    Thromb Res 123:909-13. 2009
    ..To assess clinical usefulness of CoaguChek S and XS monitors to measure International Normalised Ratio (INR) when starting warfarin in community patients...
  10. ncbi Warfarin and acetaminophen interaction
    Markus G Gebauer
    Pharmacy Department Repatriation General Hospital, Adelaide, South Australia, Australia
    Pharmacotherapy 23:109-12. 2003
    ..Patients receiving warfarin should be counseled to have their INR monitored more frequently when starting acetaminophen at dosages exceeding 2 g/day...
  11. ncbi Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial
    Alexander T Cohen
    Department of Surgery, Guy s, King s, and St Thomas s School of Medicine, London SE5 9PJ
    BMJ 332:325-9. 2006
    ..To determine the efficacy and safety of the anticoagulant fondaparinux in older acute medical inpatients at moderate to high risk of venous thromboembolism...
  12. ncbi The risk of iatrogenic bleeding in acute coronary syndromes and long-term mortality
    Magdalena Sobieraj-Teague
    Department of Haematology, Flinders Medical Centre, Adelaide, Australia
    Curr Opin Cardiol 23:327-34. 2008
    ....
  13. ncbi A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study
    Harry R Buller
    Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Blood 112:2242-7. 2008
    ..8% of those receiving standard therapy. These results with simple fixed-dose oral regimens justify phase 3 evaluations (www.ClinicalTrials.gov no.NCT00395772)...
  14. ncbi Screening for venous thrombosis by ultrasonography before hospital discharge after major joint surgery
    Alexander S Gallus
    Med J Aust 182:149-50. 2005
  15. ncbi Physician compliance with guidelines for deep-vein thrombosis prevention in total hip and knee arthroplasty
    Richard J Friedman
    Charleston Orthopedic Associates, Charleston, SC 29414, USA
    Curr Med Res Opin 24:87-97. 2008
    ..Our objective was to analyze data from the multinational Global Orthopaedic Registry (GLORY) to evaluate the compliance of surgeons with the American College of Chest Physicians (ACCP) guidelines for VTE prevention...